ClinicalTrials.Veeva

Menu

Impact of Glasses for Vision Problems on Cognitive Function in Rural Older Adults (CLEVER)

Y

Yuju Wu

Status

Not yet enrolling

Conditions

Cognition Disorders

Treatments

Device: Free Prescription Glasses

Study type

Interventional

Funder types

Other

Identifiers

NCT06836440
Gwll202464

Details and patient eligibility

About

The aim of this project is to explore whether vision correction can effectively slow cognitive decline in older adults.

The primary question it seeks to answer is: Can providing free near and/or distance vision correction glasses to older adults with refractive errors or uncorrected vision, who have normal baseline cognition and hearing, reduce the rate of cognitive decline over 36 months in a cost-effective manner? Researchers will compare the rate of cognitive decline over 36 months between older adults who receive refractive correction and those who do not.

Enrollment

963 estimated patients

Sex

All

Ages

60 to 79 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Older adults who meet all of the following criteria will be eligible to participate in this study:

    • Registered as a rural resident (holding rural household registration);
    • Age from 60 to 79 years at the time of enumeration;
    • Resident in the household for > = 3 months and planning to reside in the local area for the trial duration;
    • Distance vision impairment (VI, presenting visual acuity [VA] < 6/18 in the better-seeing eye and improving to > = 6/18 with spectacles) and/or near VI (presenting near vision < N6 at 40 cm and improving to > = N6 with spectacles);
    • Independent mobility with or without the support of a walking stick;
    • Chinese version of the Mini-Mental State Examination (C-MMSE) score above the following cut-offs (out of 30): >17 for illiterate participants, >20 for those with primary school education, >22 for those with junior high school education, and >23 for those with high school education or above.
    • Willingness to participate, to be randomized to either study group, and to adhere to the protocol

Exclusion criteria

  • Presence of glaucoma or visually significant cataract, or a history of surgical treatment for these or other major ocular conditions;
  • Consistent use of prescription spectacles and/or hearing aids;
  • Serious medical illness likely to result in loss to follow-up. Those less severely affected by conditions such as hypertension and/or diabetes will be eligible;
  • Failure on the whispered voice hearing screening test in the better ear (unable to repeat > = 3 out of 6 words whispered from behind the participant at a distance of 50 cm);

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

963 participants in 2 patient groups

Free Prescription Glasses Intervention group
Experimental group
Description:
All participants randomly assigned to the intervention group will receive free near or distance vision correction glasses based on their refractive error. Participants can choose from a variety of frames, and the research team will customize the glasses according to their pupillary distance and prescription. Once the glasses are ready, they will be provided to the participants following standard usage instructions. In case of loss or damage, participants should report it to the project team and will be provided with replacement glasses as needed. Each year, participants in the intervention group will undergo an eye exam to assess changes in vision, and their glasses prescription will be updated if necessary.
Treatment:
Device: Free Prescription Glasses
Prescription-Only Control group
No Intervention group
Description:
All participants randomly assigned to the control group will receive an eyeglass prescription, but free glasses will not be provided during the study. At the end of the study, the research team will provide near or distance vision correction glasses free of charge based on the needs of the control group participants.

Trial contacts and locations

0

Loading...

Central trial contact

Yuju Wu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems